Psych Congress produces no DEA or interagency scheduling commitment; enforcement posture on Schedule I psychedelics is unchanged despite HHS conference optics.

Predicted 2026-09-04 · Resolves 2026-11-27 · policy · USA

75%

ORACLE CONFIDENCE

⏳ Pending

Every outcome is scored publicly in the ledger.

The Psych Congress conference may generate exciting headlines and quotes from health officials, but no government agency will actually change the legal status or enforcement rules around psychedelics as a result. The DEA (the US Drug Enforcement Administration) controls drug scheduling, and changing it requires a formal legal process — not a conference. For people hoping legal access is around the corner, this means nothing has actually shifted.

Resolution rule: YES if, by 2026-11-27, no DEA or interagency scheduling commitment or enforcement-policy change tied to Psych Congress is published. Sources checked: federalregister.gov and DEA.gov news/policy pages. NO if a formal DEA scheduling action or interagency commitment appears. Check date 2026-11-27.

Conferences don't reschedule anything. DEA enforcement posture requires formal action absent from these signals.

5 new falsifiable predictions, every day at 12:05 PM ET.

Get tomorrow's Oracle →